Alaunos Therapeutics
immuno-oncology company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 11 annual filings
Revenue
$5.0K
Net Income
-$4.18M
Assets
$2.97M
EPS (diluted)
$-2.20
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-134720Alaunos Therapeutics
Summary
Alaunos Therapeutics is a public company[1].
Key Facts
- Alaunos Therapeutics's field of work was immuno-oncology[2].
- Alaunos Therapeutics's field of work was cell therapy[3].
- Alaunos Therapeutics's instance of is recorded as public company[4].
- Alaunos Therapeutics's headquarters location is recorded as Houston[5].
- +2004-00-00T00:00:00Z marks the founding of Alaunos Therapeutics[6].
- Alaunos Therapeutics's official website is recorded as https://alaunos.com/[7].
- Alaunos Therapeutics's Central Index Key is recorded as 0001107421[8].
Body
Founding
+2004-00-00T00:00:00Z marks the founding of Alaunos Therapeutics[6].
Operations
Alaunos Therapeutics's headquarters location is recorded as Houston[5].
Industry
Fields of work include immuno-oncology[2], a medical specialty[9] and cell therapy[3], a type of medical treatment[10].